Ananta Medicare Files SEBI Disclosure for 55% Stake Acquisition in Cian Healthcare
Ananta Medicare Limited has submitted regulatory disclosure to BSE under SEBI Takeover Regulations for acquiring 1,37,50,000 equity shares (55% stake) in Cian Healthcare Limited through an NCLT-approved resolution plan. The acquisition, valued at INR 13,75,00,000, was executed via preferential allotment with combined PAC holding reaching 95% of total shareholding.
*this image is generated using AI for illustrative purposes only.
Ananta Medicare Limited has completed its acquisition of a controlling stake in Cian Healthcare Limited and submitted the required regulatory disclosure to BSE Limited under SEBI Takeover Regulations. The pharmaceutical company acquired 1,37,50,000 equity shares representing a 55% stake through a court-approved resolution plan.
Regulatory Filing Details
On March 18, 2026, Sanjeev Kumar, Whole-Time Director of Ananta Medicare Limited (DIN: 02039698), submitted the formal disclosure to BSE Limited pursuant to Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition was executed through preferential allotment in a Board Meeting dated March 16, 2026.
| Parameter: | Details |
|---|---|
| Filing Date: | March 18, 2026 |
| Regulation: | SEBI Regulation 10(6) |
| Authorized Signatory: | Sanjeev Kumar (DIN: 02039698) |
| Exchange: | BSE Limited |
| Exemption Clause: | Regulation 10(1)(da) |
Acquisition Structure
The transaction involved the acquisition of 1,37,50,000 equity shares at a face value of INR 10.00 each, aggregating to INR 13,75,00,000. The acquisition was made pursuant to a Resolution Plan approved by the National Company Law Tribunal, Mumbai Bench, through its order dated December 18, 2025.
| Stakeholder: | Shares Acquired | Stake Percentage |
|---|---|---|
| Ananta Medicare Limited: | 1,37,50,000 | 55.00% |
| Mr. Rajesh Jain (PAC): | 52,50,000 | 21.00% |
| Mr. Pradeep Kumar Jain (PAC): | 47,50,000 | 19.00% |
| Total Combined Holding: | 2,37,50,000 | 95.00% |
Shareholding Transformation
The acquisition resulted in a complete transformation of Cian Healthcare's ownership structure. Prior to the transaction, none of the acquiring parties held any shares in the target company. Post-acquisition, the combined holding of Ananta Medicare Limited and its Persons Acting in Concert reaches 95.00% of the total shareholding.
NCLT Resolution Process
The acquisition falls under the exemption provided in Regulation 10(1)(da) of SEBI Takeover Regulations, as it was executed through an NCLT-approved resolution plan. Mr. Pradeep Kumar Jain was the Successful Resolution Applicant whose resolution plan received approval from the Hon'ble National Company Law Tribunal, Mumbai Bench, on December 18, 2025.
Cian Healthcare Limited's shares are listed on BSE Limited, and the transaction represents a significant corporate restructuring activity executed through the insolvency resolution process. The formal disclosure ensures compliance with regulatory requirements for substantial acquisitions exceeding the prescribed thresholds.
What strategic synergies does Ananta Medicare expect to achieve by integrating Cian Healthcare's operations into its pharmaceutical portfolio?
Will Ananta Medicare launch a mandatory open offer for the remaining 5% minority shareholders of Cian Healthcare?
How might this acquisition impact Ananta Medicare's financial performance and debt levels given the INR 137.5 crore investment?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
